<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03048162</url>
  </required_header>
  <id_info>
    <org_study_id>OMU KAEK 2016/390</org_study_id>
    <nct_id>NCT03048162</nct_id>
  </id_info>
  <brief_title>The Effects of Intravenous Fluids on Perfusion Index and Pleth Variability Index</brief_title>
  <official_title>The Evaluation of the Effects of Intravenous Fluids on Perfusion Index and Pleth Variability Index</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tokat Gaziosmanpasa University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tokat Gaziosmanpasa University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is aimed to assess the effects of intravenously administered three fluid types on
      perfusion index and pulse variability index in patients during preoperative period. Patients
      will be randomly divided into three groups. Baseline, 5th, 10th, 15th, 20th, 25th and 30th
      min non-invasive blood pressure, oxygen saturation, heart rate, room temperature, perfusion
      index and pulse variability index will be measured and recorded.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intravenous volume replacement alter the dynamics of microcirculation. Perfusion index and
      pulse variability index are the recent parameters to evaluate the tissue microcirculatory
      condition. This study is aimed to assess the effects of intravenously administered three
      fluid types on perfusion index and pulse variability index in patients during preoperative
      period. Patients will be taken to recovery room in the operating theatre and wait for 15
      minutes to balance the skin temperature of the patients to the environment. Patients will be
      randomly divided into three groups using closed envelope technique as Group L (received 500
      ml of Ringer's lactate), Group S (500 ml of saline) and Group H (received 500 ml of 6%
      hydroxyethylstarch). Baseline, 5th, 10th, 15th, 20th, 25th and 30th min non-invasive blood
      pressure, oxygen saturation, heart rate, room temperature, perfusion index and pulse
      variability index will be measured and recorded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 13, 2017</start_date>
  <completion_date type="Actual">May 15, 2017</completion_date>
  <primary_completion_date type="Actual">May 15, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perfusion index</measure>
    <time_frame>six months</time_frame>
    <description>The perfusion of the tissues</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>six months</time_frame>
    <description>Heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>six months</time_frame>
    <description>Non-invasive lood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen saturation</measure>
    <time_frame>six months</time_frame>
    <description>Blood oxygen saturation using pulse oximeter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulse variability index</measure>
    <time_frame>six months</time_frame>
    <description>The intravenous fluid requirement of the tissues</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">93</enrollment>
  <condition>Perfusion</condition>
  <arm_group>
    <arm_group_label>sodium chloride</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.9% isotonic sodium chloride, 500 ml, one package in 30 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydroxyethylstarch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>6% hydroxyethylstarch, 500 ml, one package in 30 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ringer-Lactate Infusion Solution Bag</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ringer's lactate, 500 ml, one package in 30 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium chloride</intervention_name>
    <description>500 ml of 0.9% isotonic sodium chloride</description>
    <arm_group_label>sodium chloride</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxyethylstarch</intervention_name>
    <description>500 ml of 6% Hydroxyethylstarch</description>
    <arm_group_label>Hydroxyethylstarch</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ringer-Lactate Infusion Solution Bag</intervention_name>
    <description>500 ml of Ringer-Lactate Infusion Solution Bag</description>
    <arm_group_label>Ringer-Lactate Infusion Solution Bag</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  having a fasting period of 8 hours

          -  quit smoking for 8 hours before the procedure

        Exclusion Criteria:

          -  not to participate in the study

          -  presence of peripheral vascular disease

          -  a history of upper extremity surgery

          -  presence of any kind of psychiatric disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seval Ekerer, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gaziosmanpasa University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mustafa Suren, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gaziosmanpasa University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Serkan Karaman, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gaziosmanpasa University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tugba Karaman, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gaziosmanpasa University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hakan Tapar, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gaziosmanpasa University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aynur Sahin, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gaziosmanpasa University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gaziosmanpasa University</name>
      <address>
        <city>Tokat</city>
        <zip>60200</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2017</study_first_submitted>
  <study_first_submitted_qc>February 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2017</study_first_posted>
  <last_update_submitted>May 15, 2017</last_update_submitted>
  <last_update_submitted_qc>May 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tokat Gaziosmanpasa University</investigator_affiliation>
    <investigator_full_name>Serkan Dogru</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

